International guidelines regarding the role of intravenous immunoglobulin in the management of RhD- and ABO-mediated haemolytic disease of the newborn-reconsidering the recommendations.
Saved in:
| Title: | International guidelines regarding the role of intravenous immunoglobulin in the management of RhD- and ABO-mediated haemolytic disease of the newborn-reconsidering the recommendations. |
|---|---|
| Authors: | Hansen TWR; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Akkök CA; Section of Immunohematology, Department of Immunology and Transfusion Medicine, Oslo University Hospital, Oslo, Norway., Watchko JF; Division of Newborn Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. |
| Source: | British journal of haematology [Br J Haematol] 2022 Nov; Vol. 199 (3), pp. 452-453. Date of Electronic Publication: 2022 Aug 22. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
